In Oct 2014, the FDA approved Esbriet® (pirfenidone) and OFEV® (nintedanib) for treatment of Idiopathic Pulmonary Fibrosis. These drugs are not a cure for Pulmonary Fibrosis but they slow down the progression of scarring in the lungs.

Genentech makes Esbriet. Go to Genentech website for more information.

Boehringer Ingelheim makes OFEV. Go to Boehringer Ingelheim website for more information.

Talk with your doctor to see if Esbriet or OFEV is right for you.  The use of Esbriet and OFEV for various Pulmonary Fibrosis diagnosis are expanding every day.

Also, Pulmonologists prescribe other medication such Prednisone.  In the middle of the Pulmonary Fibrosis Foundation Treatment Options website page discusses various other medications.

  • Facebook Social Icon
  • Twitter Social Icon
  • Instagram Social Icon

© 2019 The Kansas City Foundation for Pulmonary Fibrosis.  All rights reserved